OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial – Ars TechnicaRead More
OTC nasal spray seemed to cut COVID infections by 67 in midsized trial Ars Technica
Related Posts
What to expect and not expect from yet another September Apple event Ars Technica
An all-new iPhone variant, plus a long list of useful (if predictable) upgrades.
Philips Hue bulbs will be even more expensive in July And it may not end…
Some Hue products already cost more in the US than they do elsewhere.
RIP to the Macintosh HD hard drive icon 20002025 Ars Technica
Latest macOS 26 Tahoe finally excises old spinning rust icons throughout the OS.